EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of the COVID-19 pandemic and COVID-19 downgrade on non-COVID-19 respiratory diseases in Japan

Satoko Yamaguchi, Akira Okada, Sachiko Ono, Reiko Inoue, Kayo Ikeda Kurakawa, Shinji Sunaga, Toshimasa Yamauchi, Masaomi Nangaku, Takashi Kadowaki

Public Health · 2025

DOI: 10.1016/j.puhe.2025.03.031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Public Health, 2025. Verfasst von Satoko Yamaguchi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Prevention of Diabetes and Lifestyle-Related Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. Electronic a…. Hauptthemen laut MEDLINE: COVID-19, Hospitalization, Respiratory Tract Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Government of Japan Ministry of Health Labour and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: A worldwide decrease in the incidence of respiratory diseases during the coronavirus disease (COVID-19) pandemic has been reported, largely due to non-pharmaceutical interventions (NPIs). However, the impact of lifting NPIs remains unclear. In Japan, NPIs were lifted rather drastically when COVID-19 was downgraded on May 8, 2023. This study aimed to evaluate the impact of the COVID-19 pandemic and its downgrade on non-COVID-19 respiratory diseases using nationwide databases. STUDY DESIGN: Retrospective cohort study. METHODS: Monthly hospitalisation and prescription rates between January 2017 and October 2023 were collected from the JMDC insurance claims database covering 16,485,812 insured individuals. The monthly mortality rates in Japan were collected from an open data source published by Ministry of Health, Labour and Welfare of Japan. Interrupted time series analyses using seasonal autoregressive integrated moving average models were performed. RESULTS: While hospitalisation rates for diseases such as pneumonia, asthma, and aspiration pneumonia decreased during the pandemic, a step increase in hospitalisations for these diseases and prescriptions for anti-asthma drugs was observed following the COVID-19 downgrade. The pandemic impacted all age groups; however, the impact of COVID-19 downgrade was more pronounced in children aged 0-5 years. Although mortality from non-COVID-19 respiratory diseases decreased during the pandemic, no immediate step increase in mortality was observed following the downgrade. CONCLUSIONS: Although hospitalisations for pneumonia and prescriptions for anti-asthma drugs increased immediately after downgrading COVID-19, no step increase in mortality was observed presumably because older people were less affected than children.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HospitalizationRespiratory Tract DiseasesHumansJapanRetrospective StudiesChildAdultMaleFemaleMiddle AgedAgedChild, PreschoolInfantAdolescentYoung AdultPandemicsInfant, NewbornSARS-CoV-2

Stichwörter der Autor:innen

COVID-19Interrupted time series analysisNon-pharmaceutical interventionsRespiratory diseases

Autor:innen und Institutionen

  • Department of Prevention of Diabetes and Lifestyle-Related Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. Electronic address: syamaguc@m.u-tokyo.ac.jp.
  • Department of Prevention of Diabetes and Lifestyle-Related Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Department of Eat-loss Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Chofu Touzan Hospital, Tokyo, Japan.
  • Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Division of Nephrology and Endocrinology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Förderung

  • Government of Japan Ministry of Health Labour and Welfare

Zitieren

APA

Yamaguchi, S., Okada, A., Ono, S., Inoue, R., Kurakawa, K. I., Sunaga, S., Yamauchi, T., Nangaku, M., & Kadowaki, T. (2025). Impact of the COVID-19 pandemic and COVID-19 downgrade on non-COVID-19 respiratory diseases in Japan. Public Health. https://doi.org/10.1016/j.puhe.2025.03.031

Vancouver

Yamaguchi S, Okada A, Ono S, Inoue R, Kurakawa KI, Sunaga S, et al. Impact of the COVID-19 pandemic and COVID-19 downgrade on non-COVID-19 respiratory diseases in Japan. Public Health. 2025. doi:10.1016/j.puhe.2025.03.031

BibTeX
@article{Yamaguchi2025,
  author = {Yamaguchi, Satoko and Okada, Akira and Ono, Sachiko and Inoue, Reiko and Kurakawa, Kayo Ikeda and Sunaga, Shinji and Yamauchi, Toshimasa and Nangaku, Masaomi and Kadowaki, Takashi},
  title = {Impact of the COVID-19 pandemic and COVID-19 downgrade on non-COVID-19 respiratory diseases in Japan},
  journal = {Public Health},
  year = {2025},
  doi = {10.1016/j.puhe.2025.03.031}
}
Kostenlos starten →